Page last updated: 2024-10-27

gabapentin and Bilateral Deafness

gabapentin has been researched along with Bilateral Deafness in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effectiveness of gabapentin (Neurontin) improve the disease-specific quality of life in patients with moderate tinnitus."9.12Treatment of tinnitus with gabapentin: a pilot study. ( Hannley, MT; Stinnet, S; Tucci, DL; Witsell, DL, 2007)
"To evaluate the effectiveness of gabapentin (Neurontin) improve the disease-specific quality of life in patients with moderate tinnitus."5.12Treatment of tinnitus with gabapentin: a pilot study. ( Hannley, MT; Stinnet, S; Tucci, DL; Witsell, DL, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Witsell, DL1
Hannley, MT1
Stinnet, S1
Tucci, DL1

Trials

1 trial available for gabapentin and Bilateral Deafness

ArticleYear
Treatment of tinnitus with gabapentin: a pilot study.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2007, Volume: 28, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Auditory Threshold; Cyclohexanecarbo

2007